Skip to main content
Erschienen in: Journal of Anesthesia 6/2016

19.09.2016 | Clinical Report

Mitral valve repair facilitated with transapical beating heart NeoChord implantation in a non-Hodgkin’s lymphoma patient

Erschienen in: Journal of Anesthesia | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Elderly patients with severe hematological malignancies may require cardiac surgery. The combined impact of cardiopulmonary bypass (CPB) and surgical trauma is a potent inflammatory activator and is increased by intraoperative and postoperative complications. To avoid the adverse effects of CPB, minimally invasive off-pump techniques may be used in these patients. The transapical off-pump mitral valve intervention with NeoChord implantation (TOP-MINI) is a minimally invasive technique for mitral valve repair, which makes it possible to avoid the risks of CPB in selected patients, such as elderly, cancer or immunosuppressive patients. We report here the case of a 78-year-old male with B-cell non-Hodgkin’s lymphoma, who presented with severe mitral regurgitation. The patient was successfully treated with the TOP-MINI procedure.
Literatur
1.
Zurück zum Zitat Fecher AM, Birdas TJ, Haybron D, Papasavas PK, Evers D, Caushaj PF. Cardiac operations in patients with hematologic malignancies. Eur J Cardiothorac Surg. 2004;25:537–40.CrossRefPubMed Fecher AM, Birdas TJ, Haybron D, Papasavas PK, Evers D, Caushaj PF. Cardiac operations in patients with hematologic malignancies. Eur J Cardiothorac Surg. 2004;25:537–40.CrossRefPubMed
2.
Zurück zum Zitat Chan J, Rosenfeldt F, Chaudhuri K, Marasco S. Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality. Heart Lung Circ. 2012;21:255–9.CrossRefPubMed Chan J, Rosenfeldt F, Chaudhuri K, Marasco S. Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality. Heart Lung Circ. 2012;21:255–9.CrossRefPubMed
3.
Zurück zum Zitat Holmannova D, Kolackova M, Mandak J, Kunes P, Holubcova Z, Krejsek J, Vlaskova D, Andrys C. Inhibitory CD200R and proapoptotic CD95/CD95L molecules on innate immunity cells are modulated by cardiac surgery. Perfusion. 2015;30:543–55.CrossRefPubMed Holmannova D, Kolackova M, Mandak J, Kunes P, Holubcova Z, Krejsek J, Vlaskova D, Andrys C. Inhibitory CD200R and proapoptotic CD95/CD95L molecules on innate immunity cells are modulated by cardiac surgery. Perfusion. 2015;30:543–55.CrossRefPubMed
4.
Zurück zum Zitat Rucinskas K, Janusauskas V, Zakarkaite D, Aidietiene S, Samalavicius R, Speziali G, Aidietis A. Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: early results of a single-center experience. J Thorac Cardiovasc Surg. 2014;147:95–9.CrossRefPubMed Rucinskas K, Janusauskas V, Zakarkaite D, Aidietiene S, Samalavicius R, Speziali G, Aidietis A. Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: early results of a single-center experience. J Thorac Cardiovasc Surg. 2014;147:95–9.CrossRefPubMed
5.
Zurück zum Zitat Colli A, Manzan E, Rucinskas K, Janusauskas V, Zucchetta F, Zakarkaitė D, Aidietis A, Gerosa G. Acute safety and efficacy of the NeoChord procedure. Interact Cardiovasc Thorac Surg. 2015;20:575–80 (discussion 580–1).CrossRefPubMed Colli A, Manzan E, Rucinskas K, Janusauskas V, Zucchetta F, Zakarkaitė D, Aidietis A, Gerosa G. Acute safety and efficacy of the NeoChord procedure. Interact Cardiovasc Thorac Surg. 2015;20:575–80 (discussion 580–1).CrossRefPubMed
6.
Zurück zum Zitat Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, Benjamin EJ. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (The Framingham Heart Study). Am J Cardiol. 1999;83:897–902.CrossRefPubMed Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, Benjamin EJ. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (The Framingham Heart Study). Am J Cardiol. 1999;83:897–902.CrossRefPubMed
7.
Zurück zum Zitat Christiansen S, Schmid C, Löher A, Scheld HH. Impact of malignant hematological disorders on cardiac surgery. Cardiovasc Surg. 2000;8:149–52.CrossRefPubMed Christiansen S, Schmid C, Löher A, Scheld HH. Impact of malignant hematological disorders on cardiac surgery. Cardiovasc Surg. 2000;8:149–52.CrossRefPubMed
8.
Zurück zum Zitat Borde D, Gandhe U, Hargave N, Pandey K. Management of patients with hematological malignancies undergoing coronary artery bypass grafting. Ann Cardiac Anaesth. 2013;16:47–50.CrossRef Borde D, Gandhe U, Hargave N, Pandey K. Management of patients with hematological malignancies undergoing coronary artery bypass grafting. Ann Cardiac Anaesth. 2013;16:47–50.CrossRef
9.
Zurück zum Zitat Sommer SP, Lange V, Yildirim C, Schimmer C, Aleksic I, Wagner C, Schuster C, Leyh RG. Cardiac surgery and hematologic malignancies: a retrospective single-center analysis of 56 consecutive patients. Eur J Cardiothorac Surg. 2011;40:173–8.CrossRefPubMed Sommer SP, Lange V, Yildirim C, Schimmer C, Aleksic I, Wagner C, Schuster C, Leyh RG. Cardiac surgery and hematologic malignancies: a retrospective single-center analysis of 56 consecutive patients. Eur J Cardiothorac Surg. 2011;40:173–8.CrossRefPubMed
10.
Zurück zum Zitat Guler A, Sahin MA, Cingoz F, Ozal E, Demirkilic U, Arslan M. Can cardiac surgery be performed safely on patients with haematological malignancies. Cardiovasc J Afr. 2012;23:194–6.CrossRefPubMedPubMedCentral Guler A, Sahin MA, Cingoz F, Ozal E, Demirkilic U, Arslan M. Can cardiac surgery be performed safely on patients with haematological malignancies. Cardiovasc J Afr. 2012;23:194–6.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Potapov EV, Zurbrügg HR, Herzke C, Srock S, Riess H, Sodian R, Hübler S, Hetzer R. Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study. Ann Thorac Surg. 2002;74:384–9.CrossRefPubMed Potapov EV, Zurbrügg HR, Herzke C, Srock S, Riess H, Sodian R, Hübler S, Hetzer R. Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study. Ann Thorac Surg. 2002;74:384–9.CrossRefPubMed
12.
Zurück zum Zitat Kucukarslan N, Tatar T, Uzun M, Yavuz I, Ozal E, Tatar H. Coronary artery bypass surgery in patients with malignancy: a single-center study with comparison to patients without malignancy. J Card Surg. 2009;24:151–5.CrossRefPubMed Kucukarslan N, Tatar T, Uzun M, Yavuz I, Ozal E, Tatar H. Coronary artery bypass surgery in patients with malignancy: a single-center study with comparison to patients without malignancy. J Card Surg. 2009;24:151–5.CrossRefPubMed
13.
Zurück zum Zitat Barandon L, Richebé P, Munos E, Calderon J, Lafitte M, Lafitte S, Couffinhal T, Roques X. Off-pump coronary artery bypass surgery in very high-risk patients: adjustment and preliminary results. Interact CardioVasc Thorac Surg. 2008;7:789–93.CrossRefPubMed Barandon L, Richebé P, Munos E, Calderon J, Lafitte M, Lafitte S, Couffinhal T, Roques X. Off-pump coronary artery bypass surgery in very high-risk patients: adjustment and preliminary results. Interact CardioVasc Thorac Surg. 2008;7:789–93.CrossRefPubMed
14.
Zurück zum Zitat Colli A, Zucchetta F, Torregrossa G, Manzan E, Bizzotto E, Besola L, Bellu R, Sarais C, Pittarello D, Gerosa G. Transapical off-pump mitral valve repair with NeoChord implantation (TOP-MINI): step-by-step guide. Ann Cardiothorac Surg. 2015;4:295–7.PubMedPubMedCentral Colli A, Zucchetta F, Torregrossa G, Manzan E, Bizzotto E, Besola L, Bellu R, Sarais C, Pittarello D, Gerosa G. Transapical off-pump mitral valve repair with NeoChord implantation (TOP-MINI): step-by-step guide. Ann Cardiothorac Surg. 2015;4:295–7.PubMedPubMedCentral
15.
Zurück zum Zitat Rucinskas K, Janusauskas V, Zakarkaite D. Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: early results of a single-center experience. J Thorac Cardiovasc Surg. 2014;147:95–9.CrossRefPubMed Rucinskas K, Janusauskas V, Zakarkaite D. Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: early results of a single-center experience. J Thorac Cardiovasc Surg. 2014;147:95–9.CrossRefPubMed
16.
Zurück zum Zitat Colli A, Manzan E, Zucchetta F. Transapical off-pump mitral valve repair with NeoChord implantation: early clinical results. Int J Cardiol. 2016;204:23–8.CrossRefPubMed Colli A, Manzan E, Zucchetta F. Transapical off-pump mitral valve repair with NeoChord implantation: early clinical results. Int J Cardiol. 2016;204:23–8.CrossRefPubMed
17.
Zurück zum Zitat Kavakli AS, Kavrut Ozturk N, Ayoglu RU, Emmiler M, Ozyurek L, Inanoglu K, Ozmen S. Anesthetic management of transapical off-pump mitral valve repair with NeoChord implantation. J Cardiothorac Vasc Anesth (in press). Kavakli AS, Kavrut Ozturk N, Ayoglu RU, Emmiler M, Ozyurek L, Inanoglu K, Ozmen S. Anesthetic management of transapical off-pump mitral valve repair with NeoChord implantation. J Cardiothorac Vasc Anesth (in press).
Metadaten
Titel
Mitral valve repair facilitated with transapical beating heart NeoChord implantation in a non-Hodgkin’s lymphoma patient
Publikationsdatum
19.09.2016
Erschienen in
Journal of Anesthesia / Ausgabe 6/2016
Print ISSN: 0913-8668
Elektronische ISSN: 1438-8359
DOI
https://doi.org/10.1007/s00540-016-2251-9

Weitere Artikel der Ausgabe 6/2016

Journal of Anesthesia 6/2016 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.